EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Applications of CRISPR technology in cellular immunotherapy

Xiaoyu Zhou, Paul A Renauer, Liqun Zhou, Shao-Yu Fang, Sidi Chen iD

Immunological Reviews · 2023-11 · 320 (1) · 199-216

DOI: 10.1111/imr.13241 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunological Reviews, online erschienen am 14.07.2023. Verfasst von Xiaoyu Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Yale University School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Gene Editing, Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Cancer Research Institute, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CRISPR technology has transformed multiple fields, including cancer and immunology. CRISPR‐based gene editing and screening empowers direct genomic manipulation of immune cells, opening doors to unbiased functional genetic screens. These screens aid in the discovery of novel factors that regulate and reprogram immune responses, offering novel drug targets. The engineering of immune cells using CRISPR has sparked a transformation in the cellular immunotherapy field, resulting in a multitude of ongoing clinical trials. In this review, we discuss the development and applications of CRISPR and related gene editing technologies in immune cells, focusing on functional genomics screening, gene editing‐based cell therapies, as well as future directions in this rapidly advancing field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingNeoplasmsHumansImmunotherapyGenomicsTechnology

Stichwörter der Autor:innen

CRISPRT-cell therapygenomic perturbationimmune engineering

Autor:innen und Institutionen

  • Department of Genetics, Yale University School of Medicine, New Haven, Connecticut, USA.
  • System Biology Institute, Yale University, West Haven, Connecticut, USA.
  • Center for Cancer Systems Biology, Yale University, West Haven, Connecticut, USA.
  • Immunobiology Program, Yale University, New Haven, Connecticut, USA.
  • Department of Immunobiology, Yale University, New Haven, Connecticut, USA.
  • Molecular Cell Biology, Genetics, and Development Program, Yale University, New Haven, Connecticut, USA.

ORCID-Profile: Sidi Chen

Förderung

  • NCI NIH HHS
  • Cancer Research Institute
  • NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health
  • U.S. Department of Defense
  • Alliance for Cancer Gene Therapy

Zitieren

APA

Zhou, X., Renauer, P. A., Zhou, L., Fang, S. Y., & Chen, S. (2023). Applications of CRISPR technology in cellular immunotherapy. Immunological Reviews, 320(1), 199-216. https://doi.org/10.1111/imr.13241

Vancouver

Zhou X, Renauer PA, Zhou L, Fang SY, Chen S. Applications of CRISPR technology in cellular immunotherapy. Immunological Reviews. 2023;320(1):199-216. doi:10.1111/imr.13241

BibTeX
@article{Zhou2023,
  author = {Zhou, Xiaoyu and Renauer, Paul A and Zhou, Liqun and Fang, Shao-Yu and Chen, Sidi},
  title = {Applications of CRISPR technology in cellular immunotherapy},
  journal = {Immunological Reviews},
  year = {2023},
  volume = {320},
  number = {1},
  pages = {199--216},
  doi = {10.1111/imr.13241}
}
Kostenlos starten →